Zuppinger K, Molinari B, Hirt A, Imbach P, Gugler E, Tönz O, Zurbrügg R P
Helv Paediatr Acta. 1979;34(3):197-207.
Frequent transfusions improve the general well being in patients with beta-thalassemia major but carry the risk of iron intoxication including the development of diabetes mellitus. Of 22 patients with beta-thalassemia major (age 3-17 years) only 3 had a normal oral glucose tolerance. The remainder had either borderline or moderately pathological glucose curves. The mean glucose concentration was increased, and the mean insulin concentration and insulin/glucose ratio were diminished. In contrast to the oral test, the i.v. glucose tolerance test gave pathological results in only 2 of 16 patients tested. The i.v. glucose test thus may be less selective than the oral test. The mean insulin concentration was lower also after intravenous glucose, but the early insulin peak was preserved. Arginine infusion led to a normal insulin and growth hormone release. This moderate impairment of insulin release found in most of the patients leaves the hope that an efficient chelating therapy scheme might reverse beta-cell dysfunction.
频繁输血可改善重型β地中海贫血患者的总体健康状况,但存在铁中毒风险,包括糖尿病的发生。在22例重型β地中海贫血患者(年龄3 - 17岁)中,只有3例口服葡萄糖耐量正常。其余患者的葡萄糖曲线要么处于临界状态,要么呈中度病理性。平均葡萄糖浓度升高,平均胰岛素浓度和胰岛素/葡萄糖比值降低。与口服试验相比,静脉注射葡萄糖耐量试验在16例受试患者中仅有2例结果异常。因此,静脉注射葡萄糖试验的选择性可能不如口服试验。静脉注射葡萄糖后平均胰岛素浓度也较低,但早期胰岛素峰值仍存在。精氨酸输注导致胰岛素和生长激素正常释放。大多数患者中发现的这种胰岛素释放的中度损害让人希望,一种有效的螯合治疗方案可能会逆转β细胞功能障碍。